Congress Asset Management’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-35,191
Closed -$2.86M 368
2021
Q2
$2.86M Buy
35,191
+5,411
+18% +$435K 0.02% 249
2021
Q1
$2.25M Buy
29,780
+9,860
+49% +$718K 0.02% 253
2020
Q4
$1.51M Sell
19,920
-200
-1% -$13K 0.01% 253
2020
Q3
$995K Hold
20,120
0.01% 259
2020
Q2
$1.06M Hold
20,120
0.01% 258
2020
Q1
$708K Sell
20,120
-90
-0.4% -$5.26K 0.01% 269
2019
Q4
$1.77M Sell
20,210
-610
-3% -$53.3K 0.02% 260
2019
Q3
$1.77M Buy
+20,820
New +$1.85M 0.02% 263

Other funds holding NGVT

Congress Asset Management's NGVT Position: Q3 2021 in Review

Congress Asset Management sold out of Ingevity (NGVT) in Q3 2021, closing a stake of 35,191 shares — an estimated $2.86M sold.

Congress Asset Management first reported a position in NGVT in Q3 2019 and held it in 8 quarters. The position peaked at $2.86M in Q2 2021. 277 funds tracked by Wall St. Rank hold NGVT as of Q3 2021.

  • Congress Asset Management reported no remaining Ingevity position as of Q3 2021 after selling out during the quarter.
  • Congress Asset Management sold 35,191 Ingevity shares in Q3 2021, an estimated $2.86M.
  • Congress Asset Management first reported a position in Ingevity in Q3 2019 and held it in 8 quarters.
  • Congress Asset Management's Ingevity position peaked at $2.86M in Q2 2021.
  • 277 funds tracked by Wall St. Rank held Ingevity as of Q3 2021.

Based on Congress Asset Management's 13F filing for Q3 2021, filed 8 Nov 2021.